These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2914589)

  • 1. Successful treatment of hemorrhagic syndrome due to an acquired, combined deficiency of factors VII and X in a patient with multiple myeloma and amyloidosis.
    Elezović I; Djukanović R; Rolović Z
    Eur J Haematol; 1989 Jan; 42(1):105-6. PubMed ID: 2914589
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined deficiency of factor VII and X in a patient with multiple myeloma and amyloidosis].
    Elezović I; Rolović Z; Bukanović R; Bosković D; Milosević N; Marković J; Krasojević I; Blagojević R
    Srp Arh Celok Lek; 1987 Apr; 115(4):449-60. PubMed ID: 3270180
    [No Abstract]   [Full Text] [Related]  

  • 3. [Acute hemorrhagic syndrome due to acquired deficiency of factors II, VII and X. (Considerations on a case)].
    Poppa C; Enache F; Coliţă A
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1979; 31(6):569-72. PubMed ID: 44762
    [No Abstract]   [Full Text] [Related]  

  • 4. Acquired factor X deficiency and amyloidosis treated with melphalan and prednisone.
    Levin M; Chokas W
    N Engl J Med; 1987 Oct; 317(18):1155-6. PubMed ID: 3657882
    [No Abstract]   [Full Text] [Related]  

  • 5. Resolution of acquired factor X deficiency and amyloidosis with melphalan and prednisone therapy.
    Camoriano JK; Greipp PR; Bayer GK; Bowie EJ
    N Engl J Med; 1987 Apr; 316(18):1133-5. PubMed ID: 3574359
    [No Abstract]   [Full Text] [Related]  

  • 6. Acquired factor X deficiency and amyloidosis.
    Krause JR
    Am J Clin Pathol; 1977 Feb; 67(2):170-3. PubMed ID: 836622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquired factor X and antithrombin III deficiency in a patient with primary amyloidosis and nephrotic syndrome.
    Quitt M; Aghai E; David M; Kohan R; Ben Ari Y; Froom P
    Scand J Haematol; 1985 Aug; 35(2):155-7. PubMed ID: 3876596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Polychemotherapy versus melphalan-prednisone in multiple myeloma].
    Leoni P; Salvi A; Brianzoni MF; Centurioni R; Montillo M; Olivieri A
    G Clin Med; 1986 Dec; 67(5-6):291-6. PubMed ID: 3609590
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pneumonia caused by Salmonella in a patient with myeloma].
    Fernández P; Roldán V; García MC; Gil MT; Rivas C
    Sangre (Barc); 1995 Jun; 40(3):234-5. PubMed ID: 7570286
    [No Abstract]   [Full Text] [Related]  

  • 10. Marked and sustained improvement of systemic sclerosis following polychemotherapy for coexistent multiple myeloma.
    Bachleitner-Hofmann T; Machold K; Knobler R; Drach J; Grumbeck E; Gisslinger H
    Clin Exp Rheumatol; 2002; 20(1):85-8. PubMed ID: 11892717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of multiple myeloma in stages II and III with melphalan, prednisone, cyclophosphamide, vincristine and BCNU (M-2 protocol)].
    Montalbán C; Sevilla F; Zapatero A; Blanco L; Sabán J; Serrano M; Serrano Ríos M
    Rev Clin Esp; 1985 May; 176(8):392-5. PubMed ID: 3839590
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of multiple myeloma in stages I and II. Comparative study of an M-2 protocol and melphalan-prednisone].
    Montalbán C; Zapatero A; Blanco L; Sevilla F; García Laraña J; Odriozola J
    Sangre (Barc); 1984; 29(6):993-9. PubMed ID: 6549486
    [No Abstract]   [Full Text] [Related]  

  • 13. [Acquired factor X deficiency in primary amyloidosis].
    Estivill X; Zurita L; Santesmasses A; Piera J; Segura J; Félez J
    Med Clin (Barc); 1984 Jun; 83(5):223. PubMed ID: 6482586
    [No Abstract]   [Full Text] [Related]  

  • 14. [A patient with AL amyloidosis and severe factor X deficiency has been in complete haematological remission with normal factor X activity for 7 years following high-dose chemotherapy. A case study and literature review].
    Adam Z; Matýková M; Krejcí M; Pour L; Kissová J; Slechtová M; Chlupová G; Stavarová Y; Simonides J; Penka M; Mayer J; Hájek R
    Vnitr Lek; 2010 Jan; 56(1):67-78. PubMed ID: 20184115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chemotherapy of multiple myeloma].
    Golenkov AK
    Sov Med; 1991; (3):43-6. PubMed ID: 1882290
    [No Abstract]   [Full Text] [Related]  

  • 16. Vindesine in refractory multiple myeloma.
    van der Lelie H; Monasch E; Pegels HG; von dem Borne AE
    Cancer; 1986 Jan; 57(2):226-9. PubMed ID: 3942957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long unmaintained remission in multiple myeloma.
    Alexanian R
    Am J Clin Oncol; 1986 Oct; 9(5):458-60. PubMed ID: 3776910
    [No Abstract]   [Full Text] [Related]  

  • 18. [Possibility of using interferon in the treatment of multiple myeloma].
    Piatkowska-Jakubas B; Skotnicki AB; Blicharski J
    Przegl Lek; 1988; 45(10):747-50. PubMed ID: 3072590
    [No Abstract]   [Full Text] [Related]  

  • 19. Severe amyloidosis with mild multiple myeloma--an unusual course.
    Zeidman A; Sender BZ; Yarmolovsky A; Fradin Z; Mittelman M
    Haematologia (Budap); 2000; 30(1):55-9. PubMed ID: 10841327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelomatous effusion with poor response to chemotherapy.
    Kim YM; Lee KK; Oh HS; Park SK; Won JH; Hong DS; Park HS; Park JS; Lee DW
    J Korean Med Sci; 2000 Apr; 15(2):243-6. PubMed ID: 10803706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.